Skip to content

Arrowhead Research ARWR Change in Deferred Revenue

Change in Deferred Revenue at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$20.82M-51.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$2.38M+7.5%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$1.95M-76.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$99.6M+463%
Moderna logo
ModernaMRNA
$5M+117%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Arrowhead Research’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's change in deferred revenue?
Arrowhead Research (ARWR) reported change in deferred revenue of $163.36M in Q4 2025.
What does change in deferred revenue mean?
The net change in cash received for work not yet performed.
How do you interpret change in deferred revenue?
An increase signals strong future revenue potential and customer prepayments, while a decrease indicates revenue is being recognized from previously deferred balances.
How does change in deferred revenue compare across companies?
Highly relevant for biotech firms with milestone-based collaboration agreements.